10.02.20: Not intended for U.S. and UK Media

Bayer announces Phase III trials with new aflibercept 8mg formulationmehr ...
Source: Bayer IR Newsfeed: Events - Category: Pharmaceuticals Source Type: news
More News: Pharmaceuticals